Quantcast

Business News Archive - August 26, 2005

NEW YORK (Reuters) - U.S. drug company Merck & Co. might consider settling a small number of Vioxx cases involving people who claim they were harmed by the painkiller and who fit a very narrow profile, the Wall Street Journal reported on Friday.